ContractStandstill and Option Agreement • July 6th, 2011 • Medgenics, Inc. • Biological products, (no disgnostic substances)
This FOURTH AMENDMENT TO STANDSTILL AND OPTION AGREEMENT (this “Fourth Amendment”) effective this 6th day of June, 2011 (the “Effective Date”), is made and entered into by and among Baxter Healthcare Corporation, a Delaware Corporation with a place of business at One Baxter Parkway, Deerfield, IL 60015 (“BHC”), Baxter Healthcare S.A., a corporation organized under the laws of Switzerland with a place of business at Thurgauerstrasse 130, 8152 Glattpark (Opfikon) Switzerland (“BHSA”), Baxter Innovations GmbH, a corporation organized under the laws of Austria with a place of business at Industriestrasse 67, 1221 Vienna, Austria (“Innovations” and, together with BHC and BHSA, “Baxter”) and Medgenics, Inc., a Delaware corporation with a place of business at Teradion Business Park, P.O. Box 14, Misgav 20179 Israel (“Medgenics”). Baxter and Medgenics are each sometimes referred to herein as a “Party” and, collectively, as the “Parties”.
FIRST AMENDMENT TO STANDSTILL AND OPTION AGREEMENTStandstill and Option Agreement • December 16th, 2010 • Medgenics, Inc. • Biological products, (no disgnostic substances)
This FIRST AMENDMENT TO STANDSTILL AND OPTION AGREEMENT (this “Amendment”) effective 22nd day of October, 2009 (the “Effective Date”), is made and entered into by and among Baxter Healthcare Corporation, a Delaware Corporation with a place of business at One Baxter Parkway, Deerficld, IL 60015 (“BHC”), Baxter Healthcare S.A., a corporation organized under the laws of Switzerland with a place of business at Thurgauerstrasse 130, 8152 Glattpark (Opfikon) Switzerland (“BHSA”), Baxter Innovations GmbH, a corporation organized under the laws of Austria with a place of business at Industriestrasse 67, 1221 Vienna, Austria (“Innovations” and, together with BHC and BHSA, “Baxter”) and Medgenics, Inc., a Delaware corporation with a place of business at Teradion Business Park, P.O. Box 14, Misgav 20179 Israel (“Medgenics”). Baxter and Medgenics are each sometimes referred to herein as a “Party” and, collectively, as the “Parties”.
THIRD AMENDMENT TO STANDSTILL AND OPTION AGREEMENTStandstill and Option Agreement • December 16th, 2010 • Medgenics, Inc. • Biological products, (no disgnostic substances)
This THIRD AMENDMENT TO STANDSTILL AND OPTION AGREEMENT (this “Third Amendment”) effective this 20th day of October, 2010 (the “Effective Date”), is made and entered into by and among Baxter Healthcare Corporation, a Delaware Corporation with a place of business at One Baxter Parkway, Deerfield, IL 60015 (“BHC”), Baxter Healthcare S.A., a corporation organized under the laws of Switzerland with a place of business at Thurgauerstrasse 130, 8152 Glattpark (Opfikon) Switzerland (“BHSA”), Baxter Innovations GmbH, a corporation organized under the laws of Austria with a place of business at Industriestrasse 67, 1221 Vienna, Austria (“Innovations” and, together with BHC and BHSA, “Baxter”) and Medgenics, Inc., a Delaware corporation with a place of business at Teradion Business Park, P.O. Box 14, Misgav 20179 Israel (“Medgenics”). Baxter and Medgenics are each sometimes referred to herein as a “Party” and, collectively, as the “Parties”.
STANDSTILL AND OPTION AGREEMENTStandstill and Option Agreement • December 24th, 2009 • Genetic Technologies LTD • Biological products, (no disgnostic substances) • Colorado
This Agreement is made and entered into between Perlegen Sciences Inc., having its principal office at 309 University Dr., Menlo Park CA, USA (hereinafter “Grantor”), and Genetic Technologies Limited ACN 009 212 328, having its principal office at 60-66 Hanover Street, Fitzroy, Victoria, Australia 3065 (hereinafter “Grantee”).
OPTION The Trust hereby grants the Company the option to purchase up to 1.5 million shares of the Company's Class A Common Stock or equivalents held by the Trust for a purchase price of $67 per share (the "Option"). The Option can only be exercised in...Standstill and Option Agreement • November 5th, 1998 • Central Newspapers Inc • Newspapers: publishing or publishing & printing
STANDSTILL AND OPTION AGREEMENTStandstill and Option Agreement • December 16th, 2010 • Medgenics, Inc. • Biological products, (no disgnostic substances) • Illinois
THIS STANDSTILL AND OPTION AGREEMENT (this “Agreement”) is made and entered into this 22nd day of October, 2009 (the “Effective Date”), by and between Baxter Healthcare Corporation, a Delaware Corporation with a place of business at One Baxter Parkway, Deerfield, IL 60015 (“Baxter”) and Medgenics, Inc., a Delaware, corporation with a place of business at Teradion Business Park, P.O. Box 14, Misgav 20179 Israel (“Medgenics”). Baxter and Medgenics are each sometimes referred to herein as a “Party” and, collectively, as the “Parties”.
SECOND AMENDMENT TO STANDSTILL AND OPTION AGREEMENTStandstill and Option Agreement • December 16th, 2010 • Medgenics, Inc. • Biological products, (no disgnostic substances)
This SECOND AMENDMENT TO STANDSTILL AND OPTION AGREEMENT (this “Second Amendment”) effective this 29th day of December, 2009 (the “Effective Date”), is made and entered into by and among Baxter Healthcare Corporation, a Delaware Corporation with a place of business at One Baxter Parkway, Deerfield, IL 60015 (“BHC”), Baxter Healthcare S.A., a corporation organized under the laws of Switzerland with a place of business at Thurgauerstrasse 130, 8152 Glattpark (Opfikon) Switzerland (“BHSA”), Baxter Innovations GmbH, a corporation organized under the laws of Austria with a place of business at Industriestrasse 67, 1221 Vienna, Austria (“Innovations” and, together with BHC and BHSA, “Baxter”) and Medgenics, Inc., a Delaware corporation with a place of business at Tcradion Business Park, P.O. Box 14, Misgav 20179 Israel (“Medgenics”). Baxter and Medgenics are each sometimes referred to herein as a “Party” and, collectively, as the “Parties”.
Exhibit 10.8.1 STANDSTILL AND OPTION AGREEMENT This Standstill and Option Agreement is entered into this 1st day of November, 1999 by and among Rich Coast Inc. (the "Company"), Millennium Financial Group, Inc. ("Millennium") and Sovereign Partners,...Standstill and Option Agreement • October 26th, 2000 • Rich Coast Inc • Crude petroleum & natural gas
SUBJECT TO F.R.E. 408 STANDSTILL AND OPTION AGREEMENTStandstill and Option Agreement • August 14th, 2009 • Opti Inc • Semiconductors & related devices • California
This Standstill and Option Agreement is entered into this 23 day of January, 2009 between plaintiff OPTi, Inc. and Renesas Technology Corp. and Renesas Technology America, Inc.
